The threat of antimicrobial resistance in developing countries: causes and control strategies

被引:794
作者
Ayukekbong, James A. [1 ,4 ]
Ntemgwa, Michel [2 ]
Atabe, Andrew N. [3 ]
机构
[1] Redeem Biomed, Sect Clin Microbiol, POB 16, Buea, Cameroon
[2] Hlth Canada, Human Safety Div, Hlth Prod & Food Branch, Vet Drugs Directorate, Ottawa, ON, Canada
[3] Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[4] Metabiota Inc, Nanaimo, BC, Canada
关键词
Antimicrobial therapy; Developing countries; Microorganisms; Resistance; ANTIBIOTIC-RESISTANCE; RETAIL PHARMACIES; GROWING PROBLEM; RISK-FACTORS; DRUGS; DISEASE; THERAPY; IMPACT; KENYA; CARE;
D O I
10.1186/s13756-017-0208-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients' behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring.
引用
收藏
页数:8
相关论文
共 73 条
[21]   Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria [J].
Fortini, Daniela ;
Fashae, Kayode ;
Garcia-Fernandez, Aurora ;
Villa, Laura ;
Carattoli, Alessandra .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (06) :1269-1272
[22]   Retail pharmacies in developing countries: A behavior and intervention framework [J].
Goel, P ;
RossDegnan, D ;
Berman, P ;
Soumerai, S .
SOCIAL SCIENCE & MEDICINE, 1996, 42 (08) :1155-1161
[23]  
Government of Canada, 2015, FED ACT PLAN ANT RES
[24]  
Government of the United Kingdom, 2013, UK 5 YEAR ANT RES ST
[25]  
Government of the United States, 2015, NAT STRAT COMB ANT R
[26]   Antimicrobial resistance in developing countries [J].
Hart, CA ;
Kariuki, S .
BRITISH MEDICAL JOURNAL, 1998, 317 (7159) :647-650
[27]   Adult immunization: What can we learn from the childhood immunization program? [J].
Hinman, Alan R. ;
Orenstein, Walter A. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) :1532-1535
[28]   THE CENTERS-FOR-DISEASE-CONTROL [J].
IGLEHART, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (10) :604-608
[29]   Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence [J].
Kelesidis, Theodore ;
Kelesidis, Losif ;
Rafailidis, Petros. ;
Falagas, Matthew E. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) :214-236
[30]   Serotypes and antimicrobial resistance profiles of Salmonella isolates from pigs at slaughter in Kenya [J].
Kikuvi, Gideon M. ;
Ombui, Jackson N. ;
Mitema, Eric S. .
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2010, 4 (04) :243-248